Physician profile
Stacy Lewis
NPI 1922084581
$3,047.75
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $699 · 2021: $1,015 · 2022: $651.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $875.58 | 2019-2022 | |
| Novo Nordisk INC | $398.97 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $298.01 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.53 | 2020-2021 | |
| Myovant Sciences INC. | $138.42 | 2021-2022 | |
| Lilly USA, LLC | $136.94 | 2020-2021 | |
| Duchesnay USA Incorporated | $122.06 | 2019 | |
| Allergan, INC. | $101.13 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.66 | 2019-2021 | |
| Avion Pharmaceuticals | $91.04 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $90.65 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $74.34 | 2020-2021 | |
| Ethicon US, LLC | $64.91 | 2019-2021 | |
| Pfizer INC. | $53.15 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $45.50 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $38.93 | 2020-2022 | |
| Nestle Healthcare Nutrition INC. | $31.93 | 2021 | |
| Bausch Health US, LLC | $31.14 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $27.66 | 2021 | |
| Davol INC. | $24.81 | 2021 | |
| Amgen INC. | $23.58 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $22.02 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.87 | 2022 | |
| Scynexis, INC. | $19.84 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.86 | 2019 | |
| Therapeuticsmd, INC. | $15.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.90 | 2019 | |
| Amarin Pharma, INC. | $14.76 | 2021 | |
| Lupin INC. | $13.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.